trending Market Intelligence /marketintelligence/en/news-insights/trending/8ubktros54jlly9nksofjq2 content esgSubNav
In This List

WuXi AppTec gets IPO nod for Shanghai Stock Exchange

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


WuXi AppTec gets IPO nod for Shanghai Stock Exchange

China Securities Regulatory Commission gave permission to Shanghai-based WuXi AppTec Inc. to list on the Shanghai Stock Exchange, South China Morning Post reported.

The regulatory approval took only seven weeks.

The contract research organization is looking to raise about 5.7 billion Chinese yuan through issuing 104.2 million shares, according to its IPO prospectus released in February. It plans to use the funds to expand its facilities and research capabilities.

Formerly known as WuXi PharmaTech Inc., the company was privatized in 2015 in a $3.3 billion merger deal with Wuxi Merger Ltd., a wholly-own subsidiary of New WuXi Life Science Ltd.

The former entity delisted from the New York Stock Exchange in December 2015.

As of March 27, US$1 was equivalent to 6.28 yuan.